These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8543956)

  • 1. Experimental neonatal autoimmune myasthenia gravis: an immunohistochemical, ultrastructural and electrophysiological study of the motor end-plate.
    Tetsuo N; Tsujihata M; Satoh A; Yoshimura T; Nakamura T; Seto M; Nagataki S
    J Neurol Sci; 1995 Oct; 132(2):97-104. PubMed ID: 8543956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
    Fumagalli G; Engel AG; Lindstrom J
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis.
    Motomura M; Niwa M; Kataoka Y; Ootsuru I; Yoshimura T; Tsujihata M; Nagataki S
    Neurosci Lett; 1992 Aug; 143(1-2):139-42. PubMed ID: 1436658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunisation with Torpedo acetylcholine receptor.
    Elfman L
    Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal experimental autoimmune myasthenia gravis.
    Sanders DB; Cobb EE; Winfield JB
    Muscle Nerve; 1978; 1(2):146-50. PubMed ID: 571528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates.
    Hohlfeld R; Sterz R; Kalies I; Peper K; Wekerle H
    Pflugers Arch; 1981 May; 390(2):156-60. PubMed ID: 6264388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of end-plate channels in rats immunized against acetylcholine receptors.
    Alemà S; Cull-Candy SG; Miledi R; Trautmann A
    J Physiol; 1981 Feb; 311():251-66. PubMed ID: 6267252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
    Ruff RL; Lennon VA
    Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS; Kim YI; Liu HH; Johns TR
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune myasthenia gravis and cholinergic ionophore: an electrophysiologic study.
    Takamori M; Mori M; Kasai M
    Neurology; 1979 Jul; 29(7):945-50. PubMed ID: 572943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.